Skip to main content
. 2019 Feb 13;43(4):1635–1642. doi: 10.3892/ijmm.2019.4096

Figure 7.

Figure 7

In vivo anticancer efficacy study in squamous cell carcinoma-bearing xenograft model. (A) Tumor volume measurement. (B) Hematoxylin and eosin histology staining analysis. The animals were treated with respective formulations (unbound RSV, RSV-L and RSV-GL) and the experiments were initiated when the tumor volumes reached ~100 mm3. ***P<0.0001 vs. RSV. RSV, resveratrol; GE11, dodecapeptide YHWYGYTPQNVI; RSV-L, RSV-loaded liposome; GL, GE11-conjugated liposomes.